Beneficient's Schnitzer Acquires 23,300 Shares of Stock
Bruce William Schnitzer of Beneficient acquires 23,300 shares of Class A common stock, reflecting the company's commitment to executive compensation.
Codispoti reports stock transaction at American Public Education
Edward H. Codispoti, CFO of American Public Education Inc, reports a stock transaction involving 689 shares, reflecting ongoing financial activity.
Forbright's Sachs Converts Class B Shares to Class A Stock
Forbright, Inc. director Lewis A. Sachs reports share conversions, impacting the company's stock structure and reflecting strategic investment activities.
Beneficient director acquires 25,689 shares of stock
Karen Wendel of Beneficient acquires 25,689 shares of Class A common stock, reflecting executive alignment with shareholder interests.
Larivey Clifford sells shares in Worthington Steel
Larivey Clifford, an officer at Worthington Steel, reported the sale of 7,168 shares of common stock, reflecting ongoing trading activity.
Accenture CFO Angie Y. Park Reports Stock Transactions
Angie Y. Park, CFO of Accenture, disclosed stock transactions in a recent SEC filing, highlighting executive activity in the business services sector.
Brennan William Joseph Sells 12,000 Shares of Credo Technology
Brennan William Joseph reports the sale of 12,000 shares of Credo Technology Group, signaling potential changes in insider confidence in the semiconductor sector.
Canton Barry Reports Stock Transactions Amid Ginkgo Bioworks Activity
Canton Barry details stock transactions, including acquisitions and sales, impacting Ginkgo Bioworks Holdings and the biological products industry.
Castle Biosciences CEO Reports Stock Sales in SEC Filing
Castle Biosciences CEO Derek Maetzold discloses stock sales in recent SEC filing, reflecting ongoing activity in the medical laboratory services sector.
Ginkgo Bioworks CEO Jason R. Kelly Executes Stock Transactions
Ginkgo Bioworks CEO Jason R. Kelly has executed significant stock transactions, reflecting his commitment to the company amid changes in the biological products sector.
Saba Capital increases stake in BNY Mellon Strategic Municipals
Saba Capital Management, L.P. has acquired additional shares in BNY Mellon Strategic Municipals, reflecting its investment strategy in municipal securities.
HubSpot's Brian Halligan Sells 8,500 Shares of Stock
Brian Halligan, co-founder of HubSpot, sells 8,500 shares under a trading plan, retaining 59,500 shares. This reflects ongoing management strategies.
Unifi Inc. EVP Brian Moore Reports Stock Transaction
Brian David Moore of Unifi Inc. reports a stock transaction, surrendering shares to cover transfer costs. This highlights activity in the textile mill products sector.
Egawa Atsushi reports share acquisition in Accenture plc
Egawa Atsushi reports acquisition of 3,194 shares in Accenture plc, raising total ownership to 15,996 shares, highlighting executive activity in the business services sector.
Intapp CEO John T. Hall Executes Stock Transactions
Intapp, Inc. CEO John T. Hall acquires and sells shares, highlighting executive stock activity in the prepackaged software sector.
Shetty Reshma P. Reports Stock Transactions for Ginkgo Bioworks
Shetty Reshma P. disclosed multiple stock transactions involving Ginkgo Bioworks Holdings, indicating active management of equity holdings.
Ginkgo Bioworks CFO Coen Steven P. Reports Stock Transactions
Ginkgo Bioworks CFO Coen Steven P. disclosed stock transactions, acquiring 1,174 shares and selling 766 shares, reflecting executive compensation management.
Ziegler Christoph Samuel Acquires 30,000 Shares in Veraxa Biotech
Ziegler Christoph Samuel has acquired 30,000 shares in Veraxa Biotech AG, signaling confidence in the company's future in the pharmaceutical sector.
Accenture's Chief Accounting Officer Reports Share Transactions
Accenture's Chief Accounting Officer, Melissa A. Burgum, reports share transactions, indicating confidence in the company's performance amid industry competition.
Dynex Capital Co-CEO Byron L. Boston Acquires 9,180 Shares
Byron L. Boston, Co-CEO of Dynex Capital, acquires 9,180 shares, signaling confidence in the company's future amid a competitive real estate investment trust sector.